Clinical Outcome Assessments (COA)
Search documents
John Wiley & Sons(WLY) - 2026 Q3 - Earnings Call Transcript
2026-03-05 16:02
Financial Data and Key Metrics Changes - Revenue performance for the third quarter was impacted by unfavorable comparables in research and soft market conditions in learning, with overall revenue up 1% on a reported basis and flat at constant currency [26] - Adjusted Operating Income, Adjusted EPS, and Adjusted EBITDA were all up double digits, with growth rates of 22%, 19%, and 12% respectively [26] - Adjusted Operating Margin improved by 280 basis points and Adjusted EBITDA margin by 250 basis points [26][29] - Operating cash flow nearly doubled to $103 million [6] Business Line Data and Key Metrics Changes - Research publishing revenue was up 4% at constant currency, driven by record submissions and solid growth in recurring revenue models [27] - AI revenue reached $7 million in the quarter, with year-to-date AI revenue at $42 million, surpassing last year's total of $40 million [5][18] - Learning revenue was down 2% in the quarter, with a 5% decline in professional offsetting 1% growth in academic [28] Market Data and Key Metrics Changes - Research publishing continues to outpace the market, with global output up 11% [5] - Strong demand was evident across all regions, with significant growth in submissions from China and India, and a rebound in European markets [51][53] - The research publishing market is expected to grow at 3%-4%, with the company aiming to deliver at the top end of that range [10] Company Strategy and Development Direction - The company is focused on leading in research, delivering new growth in AI and adjacent markets, and driving operational excellence [9][10] - A multi-year managed services partnership with Virtusa was announced to accelerate technology transformation and operational efficiencies [30] - The company is expanding its journal portfolio and modernizing its publishing platform to benefit from AI-driven volume acceleration [14][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience of U.S. research funding, with federal investment in scientific research remaining robust [11] - The company anticipates another significant year for AI revenue, expecting to deliver between $45 million and $50 million this year [18] - Management highlighted the importance of partnerships with IQVIA and OpenEvidence as blueprints for future growth opportunities in AI [42] Other Important Information - The company has returned $126 million in dividends and share repurchases year-to-date, a 37% increase over the prior year [7] - The company is actively managing its portfolio for profitability and strategic fit, having divested a small business in research solutions earlier this year [33] Q&A Session Summary Question: What can you tell us about the momentum and direction of AI-related revenue? - Management noted that AI-related revenue has doubled from $23 million to $40 million, with expectations to reach $45 million-$50 million, indicating a strong market evolution [41][42] Question: Can you elaborate on the partnership with Virtusa and its implications for EBITDA margins? - The partnership is expected to generate productivity and agility, contributing to margin expansion objectives and propelling the company into AI-first technology infrastructure [49][50] Question: Are there any fast-growing regions outside of China and India? - Growth is being observed across various regions, including North America and Europe, with strong performance in the Middle East as well [53][54] Question: How does the professional side of the business fit into the overall strategy? - Management indicated that while the professional side produces strong earnings, it is not a growth franchise, and capital allocation will be evaluated continuously [56] Question: What other strategies are in place to unlock shareholder value? - Management emphasized organic growth investments, portfolio management, and returning capital to shareholders through share buybacks and dividends [61][62]